Breast and Cervical Cancer Program definition

Breast and Cervical Cancer Program means the program administered by OHA for providing assistance to individuals needing treatment for breast or cervical cancer as such program is described in OAR 410-200-0400 and which makes use of Medicaid funds as authorized under the Breast and Cervical Cancer Prevention and Treatment Act of 2000.
Sample 1Sample 2Sample 3
Breast and Cervical Cancer Program means the program administered by OHA for providing assistance to individuals needing treatment for breast or cervical cancer as such program is described in OAR 000-000-0000 and which makes use of Medicaid funds as authorized under the Breast and Cervical Cancer Prevention and Treatment Act of 2000.
Sample 1Sample 2Sample 3
Breast and Cervical Cancer Program means a local health department program for the early detection of breast and cervical cancer.]
Sample 1

Examples of Breast and Cervical Cancer Program in a sentence

  • Those members receiving Medicaid through the Breast and Cervical Cancer Program are entitled to full Medicaid services.

  • Services received as part of the Breast and Cervical Cancer Program are exempt from a copay as stated in OAR 410-120-1230.

  • Please Note: Administration/Project Management costs associated with your project are not to exceed 10% of the total funds being requested from the Trust.

  • Breast and Cervical Cancer Program Separate proposals and budget requests should be submitted for each of the following grants: 1.

  • Gregory Harris Synopsis As IntroducedAppropriates $11,000,000 from the General Revenue Fund to the Department of Public Health for its Breast and Cervical Cancer Program.

  • Through support provided by the Centers for Disease Control, National Breast and Cervical Cancer Early Detection Program (NBCCEDP) and non-federal funding sources, the Mississippi Breast and Cervical Cancer Program (MS-BCCP) is a screening program that supports and promotes breast and cervical cancer screening for medically underserved women that are considered high risk.

  • As a cost reimbursed subgrant, costs incurred are reimbursed through the submission of invoices as instructed by Mississippi State Department of Health, Breast and Cervical Cancer Program.

  • Because a woman must be screened by the Oregon Breast and Cervical Cancer Program and found to need treatment to be eligible for BCCM, the application process is initiated by an Oregon Breast and Cervical Cancer Program Coordinator who assists the woman in completing a BCCM application form upon receiving a diagnosis of cancer or precancerous condition.

  • Those recipients receiving Medicaid through the Breast and Cervical Cancer Program are entitled to full Medicaid services.

  • The Oregon Breast and Cervical Cancer Program of DHS Health Services provides grants to local county health departments and tribes throughout the state to administer screening and diagnostic services.

Related to Breast and Cervical Cancer Program

  • Medical cannabis card means the same as that term is defined in Section 26-61a-102.

  • Medical cannabis means the same as that term is defined in Section 26-61a-102.

  • CRAF Program means the Civil Reserve Air Fleet Program authorized under 10 U.S.C. Section 9511 et seq. or any similar or substitute program under the laws of the United States.

  • Education program means any program that is principally engaged in the provision of education, including, but not limited to, early childhood education, elementary and secondary education, postsecondary education, special education, job training, career and technical education, and adult education, and any program that is administered by an educational agency or institution.

  • Medical cannabis pharmacy means the same as that term is defined in Section 26-61a-102.

  • Educator preparation program means a planned sequence of academic courses and experiences leading to a recommendation for licensure by the State Board.

  • Treatment program means an abstinence based program or facility that is accredited by any of the following:

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Prescription monitoring program “PMP,” or “program” means the program established pursuant to 657—Chapter 37 for the collection and maintenance of PMP information and for the provision of PMP information to authorized individuals.

  • Acid Rain Program means the sulfur dioxide and nitrogen oxides air pollution control program established pursuant to Title IV of the Act under 40 CFR Parts 72-78.

  • Investment Program means a Person for whom Shipper or a direct or indirect subsidiary of Shipper acts as a general partner, managing partner or manager and the securities of which have been offered and sold to investors.

  • Opioid treatment program means a detoxification or maintenance treatment program which is required to report patient identifying information to the central registry and which is located in the state.

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.

  • sickle cell disease means a hemolytic disorder characterized by chronic anemia, painful events, and various complications due to associated tissue and organ damage; "hemolytic" refers to the destruction of the cell membrane of red blood cells resulting in the release of hemoglobin.

  • Loan Program means the State Treasurer’s Interest-Free Loan Program for Colorado School Districts authorized pursuant to the Loan Program Statutes.

  • Phase 4 Clinical Trial means a Clinical Trial of a Product conducted after Regulatory Approval of such Product has been obtained from an appropriate Regulatory Authority, which trial is (a) conducted voluntarily by a Party to enhance marketing or scientific knowledge of the Product, or (b) conducted due to a request or requirement of a Regulatory Authority.

  • Phase I Clinical Trial means a human clinical trial that is intended to initially evaluate the safety and/or pharmacological effect of a Product in subjects or that would otherwise satisfy requirements of 21 C.F.R. 312.21(a), or its foreign equivalent.

  • Modular home means a modular unit as defined in Section 15A-1-302.

  • Non-Administrator Dialysis Facility means a Dialysis Facility which does not have an agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan but has been certified in accordance with the guidelines established by Medicare.

  • Planned External Financed Generation Capacity Resource means a Planned External Generation Capacity Resource that, prior to August 7, 2015, has an effective agreement that is the equivalent of an Interconnection Service Agreement, has submitted to the Office of the Interconnection the appropriate certification attesting achievement of Financial Close, and has secured at least 50 percent of the MWs of firm transmission service required to qualify such resource under the deliverability requirements of the Reliability Assurance Agreement.

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • Energy efficiency program means a program that reduces the total amount of electricity that is

  • Phase 2 Clinical Trial means a human clinical trial, for which the primary endpoints include a determination of dose ranges or an indication of efficacy in patients being studied as described in 21 C.F.R. §312.21(b), or an equivalent clinical trial in a country in the Territory other than the United States.

  • Phase IV Clinical Trial means a product support clinical trial of a Product commenced after receipt of Regulatory Approval in the country where such trial is conducted. A Phase IV Clinical Trial may include epidemiological studies, modeling and pharmacoeconomic studies, and investigator-sponsored clinical trials studying Product that are approved by the JDC and that otherwise fit the foregoing definition.

  • Phase IIb Clinical Trial means a clinical trial of a Product on sufficient numbers of patients that is designed to provide a preliminary determination of safety and efficacy of such Product in the target patient population over a range of doses and dose regimens.

  • Individualized education program or “IEP” means a written statement for a child with a disability as defined in 14 DE Admin. Code 922.